f Green Graphene is a Boon for Managing Triple-negative Breast Cancer

References

1. WHOBreast cancer.Available From: https://www.who.int/news-room/fact-sheets/detail/breast-cancer 2023
2. KumarK. ChaturvediM. DasP. StephenS. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India.Indian J. Med. Res.20221584598607
   [Google Scholar]
3. BorriF. GranagliaA. Pathology of triple negative breast cancer.Semin. Cancer Biol.20217213614510.1016/j.semcancer.2020.06.005 32544511
   [Google Scholar]
4. MohantyD. BakshiV. RashaidM.A. ReddyT.V. DholakiaN.A. BabuA.M. Design and in-vitro characterization of betamethasone microsponge loaded topical gel.Int. J. Pharm. Res. Health Sci.20164211241129
   [Google Scholar]
5. GurunathanS. Woong HanJ. EppakayalaV. KimJ. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.Int. J. Nanomedicine201381015102710.2147/IJN.S42047 23687445
   [Google Scholar]
6. YangR. LiY. WangH. QinT. YinX. MaX. Therapeutic progress and challenges for triple negative breast cancer: Targeted therapy and immunotherapy.Mol. Biomed.2022318
   [Google Scholar]
7. Leon-FerreR.A. GoetzM.P. Advances in systemic therapies for triple negative breast cancer.BMJ2023381e07167410.1136/bmj‑2022‑071674 37253507
   [Google Scholar]
8. BasuA. UpadhyayP. GhoshA. BoseA. GuptaP. ChattopadhyayS. ChattopadhyayD. AdhikaryA. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.Biochim. Biophys. Acta, Gen. Subj.20211865312984110.1016/j.bbagen.2020.129841 33412224
   [Google Scholar]
9. GadevalA. MaheshwariR. RavalN. KalyaneD. KaliaK. TekadeR.K. Green graphene nanoplates for combined photo-chemo-thermal therapy of triple-negative breast cancer.Nanomedicine (Lond.)202015658160110.2217/nnm‑2019‑0380 32093526
   [Google Scholar]
10. MuthoosamyK. AbubakarI.B. BaiR.G. LohH.S. ManickamS. Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatment.Sci. Rep.2016613280810.1038/srep32808 27597657
    [Google Scholar]
11. RahmanM. Nanomedicine for Bioactives Healthcare applications: Healthcare applications.Berlin, HeidelbergSpringer202010.1007/978‑981‑15‑1664‑1
    [Google Scholar]
12. LiY. HanX. LinZ. WangC. FuZ. SunQ. LiC. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.Cell. Mol. Life Sci.202380616510.1007/s00018‑023‑04810‑y 37237244
    [Google Scholar]
13. YanC. HuX. GuanP. HouT. ChenP. WanD. ZhangX. WangJ. WangC. Highly biocompatible graphene quantum dots: Green synthesis, toxicity comparison and fluorescence imaging.J. Mater. Sci.20205531198121510.1007/s10853‑019‑04079‑2
    [Google Scholar]
14. YangY.Y. ZhangW. LiuH. JiangJ.J. WangW.J. JiaZ.Y. Cell-Penetrating peptide-modified graphene oxide nanoparticles loaded with rictor siRNA for the treatment of triple-negative breast cancer.Drug Des. Devel. Ther.2021154961497210.2147/DDDT.S330059 34916779
    [Google Scholar]
15. BanerjeeP.P. BandyopadhyayA. MondalP. MondalM.K. ChowdhuryP. ChakrabortyA. SudarshanM. BhattacharyaS. ChattopadhyayA. Cytotoxic effect of graphene oxide-functionalized gold nanoparticles in human breast cancer cell lines.Nucleus201962324325010.1007/s13237‑019‑00284‑1
    [Google Scholar]